Cara Tenenbaum
Health policy expert and consultant focused on FDA, digital health, women
Summary
Work
Education
Projects
Writing
FDA Decentralized Clinical Trials Draft Guidance (analysis)
May 1, 2023Analysis and summary of FDA's draft guidance on decentralized clinical trials (DCTs), covering data management, variability reduction, IRB and consent considerations, safety monitoring, and digital tools for DCTs.
FDA Regulation Must Uphold Women's Health
January 1, 2022Co-authored article arguing that FDA regulation must address long-standing gaps in attention to women's health across drugs, devices, and tests, and advocating for stronger use of the Office of Women's Health to guide sex-specific regulatory actions.
Period Poverty and the COVID-19 Pandemic: Policy Challenges and Opportunities
January 1, 2021Essay discussing policy responses to period poverty exacerbated by the COVID-19 pandemic and opportunities for legal and policy interventions to improve access to menstrual products and care.
Not Intelligent: Encoding Gender Bias
January 1, 2020Examines how AI and algorithmic systems can encode gender bias and discusses regulatory and policy approaches to mitigate harms from biased technological systems in health and related domains.